Clinical trial · Observational
Bioactive Glass as Bone Graft Substitute in Operative Treatment of Bone - a 10 Years Follow-up Study
Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.
NCT00935870CI-TRIAL-00002452completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Benign Bone Tumour Cavity | — | UNRESOLVED | — |
| Depressed Lateral Condyle Fracture | — | UNRESOLVED | — |
| Spinal Fusion | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bioactive glass and/or autogenous bone | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- A
- description
- DEPRESSED LATERAL CONDYLE FRACTURE
- interventionNames
- Device: Bioactive glass and/or autogenous bone
- label
- B
- description
- BENIGN BONE TUMOR
- interventionNames
- Device: Bioactive glass and/or autogenous bone
- label
- C
- description
- SPINAL FUSION
- interventionNames
- Device: Bioactive glass and/or autogenous bone
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Written informed consent obtained; Participation of previous clinical investigation with bioactive glass Exclusion Criteria: * The subject is unlikely to adhere to study procedures * Concurrent disease or condition that in the opinion of the investigator is contraindicating participation * Simultaneous participation in another medical device or investigational drug trial
References
Publications (0)
Data not yet available
No reference posted for this study.